Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 924 of 1,261
  1. US 8173815

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  2. WO 2012055843

    SÉMULOPARINE POUR LA PRÉVENTION D'UNE TROMBO-EMBOLIE VEINEUSE MAJEURE CHEZ UN PATIENT SUBISSANT UNE CHIRURGIE ABDOMINALE MAJEURE

    AVENTIS PHARMA SA [FR] · Granted May 3, 2012 · Expires Apr 28, 2032

    granted
  3. EP 2446882

    Arzneimittel mit dem Wirkstoff Hydromorphon mit verbesserter Lagerstabilität

    ACINO PHARMA AG [CH] · Granted May 2, 2012 · Expires Apr 27, 2032

    granted
  4. EP 2446891

    Semuloparin für Verwendung als eine antithrombotische Behandlung in den großen Bauchoperation mit verbesserter Sicherheit in Bezug auf klinisch relevante Blutungen und starken Blutungen

    AVENTIS PHARMA SA [FR] · Granted May 2, 2012 · Expires Apr 27, 2032

    granted
  5. US 8168591

    Compositions and methods related to anti-FGF agents

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  6. US 8168636

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  7. US 8168775

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  8. US 8168754

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  9. US 8168776

    Method for making a 21 nucleotide double stranded RNA chemically linked at one end

    Alnylam Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  10. US 8168800

    Aβ-binding small molecules

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  11. US 8168798

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  12. US 8168202

    Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  13. US 8168222

    Amphiphilic polymer-protein conjugates and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  14. US 8168200

    Vaccine against african horse sickness virus

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  15. US 8168391

    Method for modulating insulin production

    The Regents of the University of California · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  16. US 8168415

    Axl fusion proteins as Axl tyrosine kinase inhibitors

    The Regents of the University of Colorado · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  17. US 8168423

    Device for detecting nitrosothiol content in solution

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  18. US 8168588

    Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions

    Five Prime Therapeutics, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  19. US 8168626

    Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  20. US 8168604

    Antisense antiviral compounds and methods for treating a filovirus infection

    The United States of America as represented by the Army Medical Research and Material Command · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  21. US 8168751

    Interferon alpha mutant and its polyethylene glycol derivative

    Beijing Tri-Prime Genetic Engineering Co., Ltd · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  22. US 8168585

    Purification of peptides from colostrum

    Regen Therapeutics PLC · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  23. US 8168678

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  24. US 8168195

    Vaccines against Escherichia coli O157 infection

    The United States of America, as represented by the Department of Health and Human Services · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.